Skip to content

Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature

Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02498054
Enrollment
80
Registered
2015-07-15
Start date
2015-07-31
Completion date
2015-08-31
Last updated
2016-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

A single visit & single arm study in 80 subjects with diabetes to determine if a short educational experience with a new blood glucose meter feature improves the ability of each subject to better classify glucose results into acceptable glucose ranges.

Interventions

BEHAVIORALEducation with new meter feature.

The blood glucose meter has default settings for the colour range indicator which can be customized by the subjects and/or their healthcare professional. This colour range indicator will be presented to the subjects as a computer simulation to show subjects a range of typical blood glucose values and how this new feature would classify these results as being low (blue), in-range (green) or high (red).

Sponsors

LifeScan
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Type 1 diabetes Mellitus (T1DM) or Type 2 diabetes Mellitus (T2DM) for ≥ 3 months * Currently performing self monitoring of blood glucose (SMBG) at home * Aged ≥16 years

Exclusion criteria

* Previous use of any blood glucose meter with the colour range indicator feature to be evaluated in this study.

Design outcomes

Primary

MeasureTime frame
Success rate to categorize blood glucose values into accepted ranges.On average within 30 mins post intervention.

Secondary

MeasureTime frame
Actual time taken to categorize blood glucose values into accepted ranges on the questionnaire provided.On average within 30 mins post intervention.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026